| Literature DB >> 29570591 |
Adèle Lacroix1, Caroline Piau2, Philippe Lanotte3, Anne Carricajo4, Aurelie Guillouzouic5, Olivia Peuchant6, Anne Cady7, Clarisse Dupin8, Marie-Sarah Fangous9, Christian Martin10, Marie-Estelle Cariou11, Florence Le Gall12, Pascale Bemer5, Pierre Tattevin1.
Abstract
Eighty-five children were diagnosed with culture-confirmed nontuberculous mycobacterial cervical lymphadenitis within the MYCOMED surveillance network from 2004 to 2013. The mean incidence sharply increased from 0.57 to 3.7 per 100,000 children per year, after the discontinuation of mandatory bacillus Calmette and Guérin immunization in 2007. Cases were documented as Mycobacterium avium (62.3%), Mycobacterium intracellulare (15.3%) and Mycobacterium lentiflavum (12.9%). Outcome was favorable in all, with or without surgery or antimycobacterial treatment.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29570591 DOI: 10.1097/INF.0000000000001977
Source DB: PubMed Journal: Pediatr Infect Dis J ISSN: 0891-3668 Impact factor: 2.129